Abiopharma

Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026

Aditxt, Inc. Appoints Jeffrey M. Busch as Interim Chief Executive Officer; Founder and Former CEO of $1B NYSE Enterprise Which Delivered ~8.5% Dividends to Shareholders

Osisko Development Announces Closings of Additional US$75 Million Aggregate Principal Amount of 4.125% Convertible Senior Notes Bringing Total Offering to US$300 Million

Digital Turbine to Participate in the Roth 5th Annual Ad-Tech Summit and the 16th Annual Roth London Conference in June

Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026

Jiuzi Holdings Announces AI Intelligent Imaging Platform Achieves Milestone Progress and Advances Toward Commercial Deployment as Planned

BeOne Medicines établit une nouvelle référence en matière de contrôle à long terme de la LLC grâce aux données sur 78 mois concernant BRUKINSA présentées lors de l’ASCO 2026

Dividend in the amount of 28.136 agorot per share, record date: 9.6.26, payment 16.6.26

Alpha Cash Cardholders To Get $2.50 Back Monthly on Certain Transit in 11 U.S. Cities

LifeMD Appoints Umesh Sripad as Chief Technology Officer